Researchers find novel way to repair airway injuries

MIT tissue engineers have successfully healed airway injuries in rabbits using a technique they believe could apply to the trachea and other parts of the human body.

The work, published in the advance online issue of the Proceedings of the National Academy of Sciences the week of May 5, expands researchers' understanding of the control of tissue repair and could lead to new treatments for tracheal injuries, such as smoke inhalation and damage from long-term intubation.

The new technique heals airway injuries by placing new tracheal cells around the injury site. Two types of tracheal cells, embedded within a three-dimensional gelatin scaffold, take over the functions of the damaged tissue.

"We can begin to replicate the regulatory role cells play within tissues by creating engineered constructs with more than one cell type," said Elazer Edelman, the Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology and senior author of the paper.

Patents on the technique have been licensed to Pervasis, a company co-founded by Edelman, which develops cell-based therapies that induce repair and regeneration in a wide array of tissues.

The trachea and other respiratory tubes, like most tubes in the body, have an intricate, three-layer architecture. The inner layer, or epithelium, interacts with whatever is flowing through the tube; in the case of the trachea, air. The middle layer is composed of muscle that constricts or relaxes the tube, and the outer layer consists of connective tissue that supports microvessels and small nerves.

Most attempts at tissue regeneration seek to rebuild this complex architecture with structural precision.

However, the MIT researchers found that it is not necessary to recapture the ordered layering to heal injuries. Instead, they concentrated on restoring cellular health. When cells are intact and have regained their biological function, they need only reside near the injured tissue to enhance overall repair.

Edelman and colleagues achieved this repair state by delivering a mixture of new healthy cells derived from the epithelial lining and the nourishing blood vessels. The combination of epithelial and endothelial cells take over the biochemical role lost with cell damage. The healthy cells release growth factors and other molecules necessary for healing tissue, and can modulate their delivery in response to physiological feedback control signals.

"Cells are not just an array of bricks surrounded by mortar, nor are they passive drug pumps. Cells are active elements that respond to the dynamic changes of their environment with modulated secretion of critical factors. They don't need to be stacked in one specific fashion to function, but they do need to be healthy and near the injured tissue," said Edelman, who is also a professor at Harvard Medical School and cardiologist at Brigham and Women's Hospital.

To get the best results, both epithelial and endothelial cells must be replaced in the injured airway. "One cell type can't do it alone. With this complex disease, each regulatory cell offers something unique and together they optimize repair," Edelman said.

The cells must also be grown within a 3D scaffold, otherwise, the two types of cells will stay segregated and will not work as effectively.

Because of the similarities between the trachea and other tubes in the body, such as those of the vascular, genitourinary and gastrointestinal systems, the researchers believe their approach could translate to other organs.

"We can apply this same approach to so many different parts of the body," said Brett Zani, a postdoctoral associate in the Harvard-MIT Division of Health Sciences and Technology and lead author of the paper.

Other authors are Koji Kojima and Charles Vacanti of the Laboratory of Tissue Engineering and Regenerative Medicine at Brigham and Women's Hospital.

Source: MIT

Related stories:

Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer
A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene.
Prostate cancer spurs new nerves
Prostate cancer – and perhaps other cancers – promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research.
Scientists achieve repair of injured heart muscle in lab tests of stem cells
Researchers at Children's Hospital of Pittsburgh of UPMC have been able to effectively repair damaged heart muscle in an animal model using a novel population of stem cells they discovered that is derived from human skeletal muscle tissue.
Superglue from the sea: Synthetic sea worm glue may mend shattered knee, face bones
Sandcastle worms live in intertidal surf, building sturdy tube-shaped homes from bits of sand and shell and their own natural glue. University of Utah bioengineers have made a synthetic version of this seaworthy superglue, and hope it will be used within several years to repair shattered bones in knees, other joints and the face.
Adult brain neurons can remodel connections
Overturning a century of prevailing thought, scientists are finding that neurons in the adult brain can remodel their connections. In work reported in the Nov. 24 online edition of the Proceedings of the National Academy of Sciences (PNAS), Elly Nedivi, associate professor of neurobiology at the Picower Institute for Learning and Memory, and colleagues found that a type of neuron implicated in autism spectrum disorders remodels itself in a strip of brain tissue only as thick as four sheets of tissue paper at the upper border of cortical layer 2.
Physicists Receive Patent for Improved Cancer Therapy Device
Four physicists at the U.S. Department of Energy's Brookhaven National Laboratory have been awarded U.S. Patent No. 7,432,516 B2 for the design of a “medical synchrotron” capable of delivering precision doses of proton radiation to cancerous tumors with minimal damage to surrounding healthy tissue. The new device would be more precise and less costly than existing proton-therapy systems, potentially increasing the availability and benefits of this treatment for cancer patients worldwide. The Brookhaven scientists are now seeking industrial partners to license and commercialize the technology.
Scientists gain insight into the cause and possible treatment of motor neurone disease
BBSRC-funded researchers at UCL along with collaborators at King's College London have identified a molecule that could be the key to understanding the cause of neurodegenerative diseases such as motor neurone disease (MND). This insight opens up the possibilities for developing new treatments to treat these devastating progressive conditions. The research is published today (17 November 2008) in the Proceedings of the National Academy of Sciences (PNAS) and is funded by BBSRC (Biotechnology and Biological Sciences Research Council) with the Medical Research Council and the Wellcome Trust.
Scientists discover new cause of fatal brain injury from acute viral meningitis
In a November 16 advance, online publication of the journal Nature, the researchers say their discovery revamps common beliefs about how such potentially lethal infections may be ravaging the brain and suggests the possibility of new treatments.

News discussion:

Medicine & Health news